RETRACTED ARTICLE: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
Zhe Huang, Liang Zeng, Zhaohui Ruan, Qun Zeng, Huan Yan, Wenjuan Jiang, Xiong Yi, Chunhua Zhou, H Yang, Li Kuan Liu, Jiacheng Dai, Nachuan Zou, Shidong Xu, Ya Wang, Zhan Wang, Jun Deng, Xue Chen, Jing Wang, Hua Xiang, Xiaomei li, Boris Duchemann, Guoqiang Chen, Yang Xia, Tony Mok, Christoph Scheiermann, Francis Lévi, Nong Yang, Yongchang Zhang
Topics & Concepts
MedicineHazard ratioClinical endpointAdverse effectInternal medicineConfidence intervalRandomized controlled trialOncologyLung cancerPhases of clinical researchRetrospective cohort studySurgeryClinical trialLungProgression-free survivalProspective cohort studyLower riskDiscontinuationRespiratory diseaseProportional hazards modelStage (stratigraphy)MorningCancer Immunotherapy and BiomarkersCircadian rhythm and melatoninChronic Obstructive Pulmonary Disease (COPD) Research